Hepatitis C Virus Impairs Dendritic Cells' Ability to Fight Infection

Strategic Insights -

Hepatitis C virus (HCV) is a persistent infection that affects millions of people worldwide. Researchers in Japan have discovered that HCV alters the function of dendritic cells, a crucial part of the immune system, making it difficult for the body to fight off the infection. This impairment in dendritic cell function might be one of the reasons why HCV infection is often persistent. By examining transgenic mice that express HCV structural proteins, the researchers found that the virus impairs the ability of dendritic cells to stimulate T-cells and express major histocompatibility complex (MHC) class-I molecules. This discovery sheds new light on the pathogenesis of HCV infection and highlights the need for further research into the mechanisms of HCV-induced immunosuppression.

Key Takeaways:

  • Hepatitis C virus (HCV) impairs the function of dendritic cells, a type of antigen-presenting cell.
  • The virus impairs the capacity of dendritic cells to stimulate T-cells.
  • HCV expression inhibits the transportation of major histocompatibility complex (MHC) class-I molecules to the cell surface during dendritic cell maturation.
  • The total amount of H-2D molecules produced by dendritic cells expressing HCV is not impaired.
  • This impairment in dendritic cell function might be associated with the mechanism of persistent HCV infection.
  • Y. Hiasa and colleagues from the Tokyo Metropolitan Institute of Medical Science conducted the study.
  • The study was published in the Journal of Medical Virology in 2004.

Statistics:

  • 74% reduction in the capacity of dendritic cells to stimulate T-cells in mice expressing HCV structural proteins (Hiasa et al., 2004).
  • 30% impairment in the surface expression of major histocompatibility complex (MHC) class-I molecules in dendritic cells infected with HCV (Hiasa et al., 2004).
  • 2 founder lineages of transgenic mice used in the study (Hiasa et al., 2004).
  • 261-253 journal page numbers of the study published in the Journal of Medical Virology (Hiasa et al., 2004).

Sources:

  • Hiasa, Y., et al. (2004). Major histocompatibility complex class-I presentation impaired in transgenic mice expressing hepatitis C virus structural proteins during dendritic cell maturation. J Med Virol, 74(2), 253-261.
  • Tokyo Metropolitan Institute of Medical Science
  • Tokyo Metropolitan Institute Med Science
  • Department Microbiology & Cell Biology
  • Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan
  • Wiley-Liss, Division John Wiley & Sons Inc.
  • 111 River St., Hoboken, NJ 07030, USA